[Federal Register Volume 66, Number 219 (Tuesday, November 13, 2001)]
[Notices]
[Page 56833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-28317]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in section 552b(6), as amended. The 
discussions could disclose personal information concerning NCI Staff 
and/or its contractors, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Dates: December 4-5, 2001.
    Open: December 4, 2001, 8:45 a.m. to 4 p.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 900 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, 
(301) 496-5147.

    Name of Committee: National Cancer Advisory Board.
    Closed: December 4, 2001, 4 p.m. to Recess.
    Agenda: Review intramural program site visit outcomes; 
Discussion of confidential personnel issues.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin, R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, 
(301) 496-5147.

    Name of Committee: National Cancer Advisory Board.
    Open: December 5, 2001, 8:30 a.m. to Adjournment.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, 
(301) 496-5147,

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Information is also available on the Institute's homepage: 
deainfo.nci.nih.gov/odvisory/ncab.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399 Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 2, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-28317 Filed 11-9-01; 8:45 am]
BILLING CODE 4140-01-M